Vincerx Pharma Reports Strong Performance in Q4 with Better-than-Expected GAAP EPS
Monday, 1 April 2024, 05:04
Vincerx Pharma GAAP EPS Results
Vincerx Pharma press release (VINC) announced a fourth-quarter GAAP EPS of -$0.23, exceeding expectations by $0.06. The company disclosed holding $12.8 million in cash and cash equivalents as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.